Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Webinar: Investigating Out-of-Specification (OOS) Test Results in the Laboratory; FDA Guidance and Latest Expectations (May 5, 2026)" webinar has been ...
Late last year, Novartis explained how in certain circumstances, it was providing out-of-specification (OOS) doses of its cell therapy Kymriah (tisagenlecleucel) under a compassionate use program in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results